NCT02603016

Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma

Phase 1 Study of Clinical Nutrition That Research Safty and Efficacy in Lung Neoplasms And Breast Carcinoma

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 480 (actual)
• Sponsor: Chinese PLA General Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the efficacy of clinical nutrition to treat lung neoplasms and breast carcinoma.We estimate there will be 480 patients accepted.120 patients will receive GLSE compound,120 patients will recrive Maitake mushroom extract compound,120 patients will recrive Rinseng compound,and 120 patients will be as blank countrol group.Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma

Detailed description

GLSE compound、Maitake mushroom extract compound and Rinseng compound have different mechanism on enhancing immunity.This clinicaltrial compare them the immune effect in the progress of treating lung neoplasms and breast carcinoma.Within the 42 days,we will abide by the plan to evaluate the immunity enhancement by monitoring mmune effector molecules.

Conditions

• Lung Neoplasms
• Breast Neoplasms

Interventions

Type	Name	Description
DRUG	GLSE compound
DRUG	Maitake mushroom extract compound
DRUG	Ginseng compound

Timeline

• Start date: 2015-11-01
• Primary completion: 2016-11-01
• Completion: 2017-02-01
• First posted: 2015-11-11
• Last updated: 2017-03-14

Locations

1 site across 1 country: China